Chronic migraines affect over 39 million Americans, with many exhausting traditional medications only to find limited relief. Imagine a treatment that doesn’t involve more pills, injections, or preventive drugs with debilitating side effects—a non-invasive approach that directly targets the brain pathways triggering your pain.
Transcranial Magnetic Stimulation (TMS) for migraines offers FDA-approved relief, with clinical studies showing 38% of migraine sufferers were pain-free two hours after treatment, compared to only 17% in the control group.
Transcranial Magnetic Stimulation (TMS) for migraine is an FDA-approved non-invasive procedure that uses precisely targeted magnetic pulses to stimulate the cortex (outer brain layer). The stimulation modulates neural circuits involved in pain processing, essentially “recalibrating” your brain’s migraine threshold.
During a TMS session, a magnetic coil is positioned over a specific scalp location—typically the motor cortex, an area crucial for pain modulation and sensory processing. The coil delivers painless magnetic pulses that penetrate into the brain tissue below. These pulses trigger the release of neurotransmitters and activate neural pathways that reduce trigeminal nerve excitability, enhance your brain’s natural pain-suppression systems, normalize cortical activity, and decrease inflammatory markers associated with migraines.
Each acute TMS session lasts approximately 3.5–4 minutes, making it ideal for aborting migraines as they start. Preventive sessions typically last 20 minutes and are usually administered 1–2 times weekly for 6–10 weeks.
TMS therapy for migraines operates in two distinct ways. Acute TMS involves using a handheld device when you feel a migraine beginning to abort the headache before it escalates. The pivotal clinical trial (TMPROVE) published in Neurology showed that 39% of patients achieved complete pain relief within 2 hours, while 67% achieved mild pain or pain freedom compared to 32% with placebo.
Preventive TMS involves regular sessions (1–2 times weekly for 6–10 weeks) to reduce how often migraines occur in the first place. Studies show that 38% of chronic migraine sufferers achieve 50% or greater reduction in migraine headache days, with most patients noticing improvement by week 4 and peak benefit around week 8–12. For someone experiencing 15–20 migraines monthly, a 50% reduction could mean dropping to 7–10 migraines monthly—a life-changing improvement.
Complete Mind Care offers both approaches, often combining them for maximum efficacy. We develop personalized protocols tailored to your specific migraine pattern.
TMS offers distinct advantages compared to traditional migraine therapies. Unlike triptans and other acute medications, TMS has no rebound headache risk and works through direct brain stimulation rather than chemical mechanisms.
Unlike Botox injections, TMS requires no quarterly procedures and works faster, often providing relief within 4 minutes for acute migraines. Unlike CGRP monoclonal antibodies, TMS doesn’t require monthly injections costing thousands of dollars.
Unlike preventive medications like topiramate or propranolol, TMS causes no weight gain, cognitive fog, sexual dysfunction, or systemic side effects. No dependency develops, and no medication interactions occur. You remain fully awake and alert during treatment—many patients read or work during sessions.
Ideal candidates include chronic migraine sufferers (15+ headache days monthly), patients with treatment-resistant migraines who’ve failed two or more preventive medications, those experiencing medication intolerance or side effects, patients at risk for medication overuse, and anyone wanting to reduce their medication burden. Even patients with episodic migraines (5–14 days monthly) often benefit from preventive TMS.
Most patients are good candidates with proper medical screening. During your initial evaluation, we conduct a comprehensive migraine assessment including frequency, triggers, associated symptoms, medication history, neurological examination, and quality of life impact. This determines your candidacy and guides treatment selection
TMS for migraine has an excellent safety profile. The most common side effect is mild scalp tenderness at the stimulation site, which typically resolves within hours. Some patients experience a tapping sensation during stimulation (expected and non-bothersome) or mild dizziness (rare). Serious side effects like seizures are vanishingly rare when proper screening occurs. TMS does not cause cognitive impairment, memory loss, weight gain, or dependency.
Most patients notice acute TMS results immediately—either the migraine aborts or significantly reduces within the 4-minute treatment window. Preventive TMS shows noticeable reduction in migraine frequency by week 4, with many patients reporting 30–50% fewer migraines by week 8–12.
Our psychiatrists and neurological specialists have extensive experience treating chronic migraines with TMS. We understand migraine neurobiology deeply and customize protocols to your specific migraine pattern. With convenient locations in Villanova and Horsham, you can attend preventive sessions without excessive travel time.
Many of our migraine TMS patients have failed multiple preventive medications and procedures. We excel at helping the most difficult-to-treat cases. If you have comorbid depression or anxiety, your TMS migraine treatment can be integrated with comprehensive mental health care, as TMS benefits both conditions.
Acute TMS works within minutes. Preventive TMS shows noticeable improvement by week 4, with peak benefit around week 8–12.
Approximately 38% achieve 50%+ reduction in migraine days, with another 40% experiencing modest 25–49% reduction.
No. You may feel tapping sensations and hear clicking sounds, but it’s painless and well-tolerated.
Many insurance plans cover TMS for migraine, especially after failing preventive medications. We verify coverage before starting treatment.
With maintenance sessions (2–4 times monthly), benefits typically persist indefinitely.
Yes. TMS can be combined with Botox, CGRP monoclonal antibodies, or preventive medications for optimized results.
Chronic migraines don’t have to control your life. With TMS—a non-invasive, non-medication approach backed by clinical evidence—many patients achieve dramatic reduction in migraine frequency and severity for the first time in years.
FDA Approval Note: TMS is FDA-cleared for migraine treatment. Single-pulse TMS (sTMS) devices received FDA clearance in 2013 for acute migraine relief and expanded clearance in 2017 for both acute and preventive treatment in adults and adolescents 12+. While repetitive TMS (rTMS) and Deep TMS are FDA-approved for depression and OCD, their use for migraines may be offered as specialized treatment protocols.
Conditions Treated
721 Dresher Rd # 1100, Horsham, PA 19044
795 E. Lancaster Ave Suite 210, Villanova, PA 19085
Complete Mind Care was founded to provide comprehensive mental health support delivered by a team of expert professionals, in a world-class facility close to home — so you can build a lasting foundation for wellness without traveling far to get there. We also accept 40+ insurance carriers, making quality care more accessible.
Don’t see your insurance listed? Call our office at 215-607-7250 or 215-918-7939 to verify coverage.
